GlaxoSmithKline: Psoriasis trials
The registry lists 26 Psoriasis studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 15 have results posted.
Phase 1 10Phase 2 9Phase 3 4Phase 4 3No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis ParticipantsCompletedNCT04316585Phase 1Results posted
- A Study of GSK2981278 Ointment in Subjects With Plaque PsoriasisCompletedNCT03004846Phase 1/2Results posted
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With PsoriasisCompletedNCT02776033Phase 2Results posted
- A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque PsoriasisCompletedNCT02564042Phase 2Results posted
- A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque PsoriasisCompletedNCT02195349Phase 1Results posted
- Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate CreamCompletedNCT02075632Phase 2Results posted
- A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque PsoriasisCompletedNCT01782664Phase 2Results posted
- Efficacy of Alitretinoin Treatment in Patients With Pustular Form of PsoriasisCompletedNCT01245140Phase 2Results posted
- Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type PsoriasisCompletedNCT01154101Phase 2Results posted
- The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body PsoriasisCompletedNCT01139580Phase 3Results posted
- A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type PsoriasisCompletedNCT00852761Phase 4Results posted
- Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle FoamCompletedNCT00842153Phase 4Results posted
- Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque PsoriasisCompletedNCT00716144Phase 2Results posted
- Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 StudiesCompletedNCT00689481Phase 3Results posted
- Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 StudiesCompletedNCT00688519Phase 3Results posted
- GSK2894512 Vehicle-Controlled Study for Adult Plaque PsoriasisWithdrawnNCT03202004Phase 3
- A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult SubjectsWithdrawnNCT03201978Phase 1
- A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic ArthritisWithdrawnNCT02671188Phase 1
- Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque PsoriasisCompletedNCT02548052Phase 1
- A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy SubjectsCompletedNCT01984775Phase 1
- A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.CompletedNCT01899755Phase 1
- A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male VolunteersCompletedNCT01702493Phase 1
- Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type PsoriasisWithdrawnNCT00832364Phase 4
- An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type PsoriasisCompletedNCT00725348Phase 2
- Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034CompletedNCT00358384Phase 1
- A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive PatientsCompletedNCT00002286Not applicable